Riskpilot← Back to searchSign inGet full accessVITROLIFE A/S
A/SActiveCVR 27406793Jens Juuls Vej 16Manufacture of medical and dental instruments and supplies · NACE 3250Est. 2003118 employees
Revenue 2024
DKK 249,7M
+15% vs 2023
EBITDA margin
72.8%
+20% vs 2023
Equity ratio
83.8%
Financial strength
Net profit 2024
DKK 130,3M
+26% vs 2023
| Revenue | DKK 249,7M | +15% |
| EBITDA | DKK 181,9M | +20% |
| Net profit | DKK 130,3M | +26% |
| Total assets | DKK 377,8M | +32% |
| Equity | DKK 316,7M | +32% |
| Employees | 118 | — |
Legal name
VITROLIFE A/S
CVR number
27406793
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
20. oktober 2003
Share capital
DKK 3.741.200
Employees
118 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem eller af en direktør.
Company purpose
Selskabets formål er er at udvikle, demonstrere og kommercialisere udstyr til optimering af fertilitetsbehandling samt enhver aktivitet, der efter direktionens skøn står i forbindelse hermed.
Address
Jens Juuls Vej 16
Phone
+4572217900
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | 23.954 | 22.465 | 11.866 | 56.487 | 65.346 | 135.054 | 145.250 | 183.031 | 130.352 | 194.179 | 219.325 | 216.829 | 249.707 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -24.141 | -37.585 | -36.648 | -27.981 | -37.607 | -41.718 | -46.693 | -50.624 | -47.467 | -54.991 | -59.938 | -65.298 | -67.854 |
| EBITDA | — | — | — | — | — | — | — | — | -186 | -15.120 | -24.782 | 28.506 | 25.845 | 93.335 | 98.557 | 132.407 | 82.885 | 139.187 | 159.387 | 151.531 | 181.853 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -11.324 | -14.212 | -35.411 | -11.189 | -7.183 | -13.703 | -11.823 | -9.875 | -9.867 | -17.028 | -20.319 | -19.132 | -19.186 |
| EBIT | — | — | — | — | — | — | — | — | -11.511 | -29.333 | -60.193 | 17.317 | 18.662 | 79.633 | 86.734 | 122.532 | 73.018 | 122.159 | 139.068 | 132.399 | 162.666 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.209 | -10.619 | -12.729 | 28.538 | -308 | -2.825 | 834 | -1.589 | 68 | 1.480 | -1.105 | -247 | 4.024 |
| Profit before tax | — | — | — | — | — | — | — | — | -16.720 | -39.951 | -72.922 | 45.855 | 18.354 | 76.807 | 87.568 | 120.943 | 73.086 | 123.640 | 137.963 | 132.152 | 166.691 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -2.650 | -5.850 | -14.950 | 3.139 | 6.772 | 14.291 | 19.265 | 26.645 | 15.770 | 27.121 | 30.205 | 29.000 | 36.406 |
| Net profit | — | — | — | — | — | — | — | — | -14.070 | -34.101 | -57.972 | 42.716 | 11.582 | 62.517 | 68.303 | 94.298 | 57.316 | 96.519 | 107.758 | 103.153 | 130.285 |
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115.777 | 139.853 | 113.695 | 133.720 | 122.781 | 187.709 | 133.805 | 209.709 | 266.724 | 323.167 | 295.855 | 286.187 | 377.793 |
| Equity | — | — | — | — | — | — | — | — | 78.124 | 49.763 | 43.773 | 86.458 | 98.040 | 160.557 | 58.860 | 153.157 | 210.583 | 247.479 | 255.754 | 239.414 | 316.677 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.463 | 45.181 | 0 | 0 | 0 | -1.848 | 14.677 | 12.138 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.654 | 43.627 | 24.741 | 46.625 | 20.826 | 25.616 | 71.484 | 37.369 | 38.044 | 70.114 | 35.452 | 42.146 | 54.845 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.654 | 90.090 | 69.922 | 46.625 | 20.826 | 25.616 | 71.484 | 52.046 | 50.182 | 70.114 | 35.452 | 42.146 | 54.845 |
EBITDA margin
72.8%
This company
15.8%
Market median
+361% vs market
20042024
Equity ratio
83.8%
This company
38.2%
Market median
+119% vs market
20042024
Return on equity
41.1%
This company
18.4%
Market median
+123% vs market
20042024
Net profit margin
52.2%
This company
8.1%
Market median
+544% vs market
20042024
Asset turnover
0.66×
This company
1.12×
Market median
-41% vs market
20042024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20042024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via CVR / Virk · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via CVR / Virk · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via CVR / Virk · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via CVR / Virk · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via CVR / Virk · Period 2007-01-01 – 2007-12-31
- Annual report 2006Filed via CVR / Virk · Period 2006-01-01 – 2006-12-31
- Annual report 2005Filed via CVR / Virk · Period 2005-01-01 – 2005-12-31
- Annual report 2004Filed via CVR / Virk · Period 2003-10-20 – 2004-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DE Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
MR Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
SB Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
JK Management | Management | 2003 | — | — |
CB Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2014 | — | — | |
TF | Board of Directors | 2025 | — | — |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VITROLIFE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Erik Rickard Ericsson | Chief Executive Officer | 0 companies |
| Michael Reeslev | Chief Executive Officer | 0 companies |
| Steffen Broe Nielsen | Chief Executive Officer | 0 companies |
| Jens Kristian Ellekilde Gundersen | Management | 0 companies |
| Claus Bisgaard | Chief Executive Officer | 0 companies |
| Claus Jørgensen | Board of Directors | 0 companies |
| Peter Mørch Eriksen | Board of Directors | 0 companies |
| Sten Jakob Hedén | Chairman | 0 companies |
| Manuel de la Llave | Board of Directors | 0 companies |
| Bo Lars Risberg | Board of Directors | 0 companies |
| Sylvie Elisabeth Bove | Board of Directors | 0 companies |
| Tom Henning Riisom | Chairman | 0 companies |
| Kirsten Marie Jakobsen | Board of Directors | 0 companies |
| Christian Grøndahl | Chairman | 0 companies |
| Hans Jørgen Angaard Madsen | Board of Directors | 0 companies |
| Per Christian Gernow | Board of Directors | 0 companies |
| Jens Borum | Board of Directors | 0 companies |
| Søren Nielsen | Board of Directors | 0 companies |
| Per Stefan Harry Pettersson | Board of Directors | 0 companies |
| Tom Faes | Board of Directors | 0 companies |
| Carl Erik Skovgaard | Board of Directors | 0 companies |
| Lars Rabe Tønnesen | Board of Directors | 0 companies |
| Tony Patrik Tolf | Chairman | 0 companies |
| Erik Mikael Engblom | Board of Directors | 0 companies |
| Hans Thomas Axelsson | Chairman | 0 companies |